Skip to main content
Presence of myeloma precursor could advance disease within 5 years
8/13/2019

A study found that individuals with low- or intermediate-risk monoclonal gammopathy of undetermined significance, a multiple myeloma precursor, can progress to high-risk MGUS and may develop into multiple myeloma within five years, according to a study in JAMA Oncology. Based on their findings, Memorial Sloan Kettering Cancer Center researchers recommend that all patients with MGUS undergo risk assessment and blood testing.

Full Story: